Aimless mutants of Cryptococcus neoformans: Failure to disseminate

Fungal Biology Reviews

Volumn 26, Issue 2-3, 2012, Pages 61-72

  Griffiths, E J ^a   Kretschmer, M ^a   Kronstad, J W ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Blood brain barrier; Fungal pathogens; Invasion

Indexed keywords

FILOBASIDIELLA NEOFORMANS; FUNGI;

EID: 84867878431     PISSN: 17494613     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fbr.2012.02.004     Document Type: Review

References (108)

1. Alspaugh J.A., Cavallo L.M., Perfect J.R., Heitman J. RAS1 regulates filamentation, mating and growth at high temperature of Cryptococcus neoformans. Mol. Microbiol. 2000, 36:352-365.
2. Alvarez M., Casadevall A. Phagosome extrusion and host-cell survival after Cryptococcus neoformans phagocytosis by macrophages. Curr. Biol. 2006, 16:2161-2165.
3. Alvarez M., Casadevall A. Cell-to-cell spread and massive vacuole formation after Cryptococcus neoformans infection of murine macrophages. BMC Immunol. 2007, 8:16.
4. Ballou E.R., Nichols C.B., Miglia K.J., Kozubowski L., Alspaugh J.A. Two CDC42 paralogues modulate Cryptococcus neoformans thermotolerance and morphogenesis under host physiological conditions. Mol. Microbiol. 2010, 75:763-780.
5. Barbosa F.M., Fonseca F.L., Holandino C., Alviano C.S., Nimrichter L., Rodrigues M.L. Glucuronoxylomannan-mediated interaction of Cryptococcus neoformans with human alveolar cells results in fungal internalization and host cell damage. Microbes Infect. 2006, 8:493-502.
6. Barbosa F.M., Fonseca F.L., Figueiredo R.T., Bozza M.T., Casadevall A., Nimrichter L., Rodrigues M.L. Binding of glucuronoxylomannan to the CD14 receptor in human A549 alveolar cells induces interleukin-8 production. Clin. Vaccine Immunol. 2007, 14:94-98.
7. Bonazzi M., Lecuit M., Cossart P. Listeria monocytogenes internalin and E-cadherin: from bench to bedside. Cold Spring Harb. Perspect. Biol. 2009, 1:a003087.
8. Bonazzi M., Lecuit M., Cossart P. Listeria monocytogenes internalin and E-cadherin: from structure to pathogenesis. Cell Microbiol. 2009, 11:693-702.
9. Casadevall A. Cryptococci at the brain gate: break and enter or use a Trojan horse?. J. Clin. Invest. 2010, 120:1389-1392.
10. Chang Y.C., Kwon-Chung K.J. Complementation of a capsule-deficient mutation of Cryptococcus neoformans restores its virulence. Mol. Cell. Biol. 1994, 14:4912-4919.
11. Chang Y.C., Penoyer L.A., Kwon-Chung K.J. The second capsule gene of Cryptococcus neoformans, CAP64, is essential for virulence. Infect. Immun. 1996, 64:1977-1983.
12. Chang Y.C., Kwon-Chung K.J. Isolation of the third capsule-associated gene, CAP60, required for virulence in Cryptococcus neoformans. Infect. Immun. 1998, 66:2230-2236.
13. Chang Y.C., Kwon-Chung K.J. Isolation, characterization, and localization of a capsule-associated gene, CAP10, of Cryptococcus neoformans. J. Bacteriol. 1999, 181:5636-5643.
14. Chang Y.C., Jong A., Huang S., Zerfas P., Kwon-Chung K.J. CPS1, a homolog of the Streptococcus pneumoniae type 3 polysaccharide synthase gene, is important for the pathobiology of Cryptococcus neoformans. Infect. Immun. 2006, 74:3930-3938.
15. Chang Y.C., Bien C.M., Lee H., Espenshade P.J., Kwon-Chung K.J. Sre1p, a regulator of oxygen sensing and sterol homeostasis, is required for virulence in Cryptococcus neoformans. Mol. Microbiol. 2007, 64:614-629.
16. Charlier C., Nielsen K., Daou S., Brigitte M., Chretien F., Dromer F. Evidence of a role for monocytes in dissemination and brain invasion by Cryptococcus neoformans. Infect. Immun. 2009, 77:120-127.
17. Chayakulkeeree M., Sorrell T.C., Siafakas A.R., Wilson C.F., Pantarat N., Gerik K.J., Boadle R., Djordjevic J.T. Role and mechanism of phosphatidylinositol-specific phospholipase C in survival and virulence of Cryptococcus neoformans. Mol. Microbiol. 2008, 69:809-826.
18. Chayakulkeeree M., Johnston S.A., Oei J.B., Lev S., Williamson P.R., Wilson C.F., Zuo X., Leal A.L., Vainstein M.H., Meyer W., Sorrell T.C., May R.C., Djordjevic J.T. SEC14 is a specific requirement for secretion of phospholipase B1 and pathogenicity of Cryptococcus neoformans. Mol. Microbiol. 2011, 80:1088-1101.
19. Chen S.H., Stins M.F., Huang S.H., Chen Y.H., Kwon-Chung K.J., Chang Y., Kim K.S., Suzuki K., Jong A.Y. Cryptococcus neoformans induces alterations in the cytoskeleton of human brain microvascular endothelial cells. J. Med. Microbiol. 2003, 52:961-970.
20. Chretien F., Lortholary O., Kansau I., Neuville S., Gray F., Dromer F. Pathogenesis of cerebral Cryptococcus neoformans infection after fungemia. J. Infect. Dis. 2002, 186:522-530.
21. Chun C.D., Liu O.W., Madhani H.D. A link between virulence and homeostatic responses to hypoxia during infection by the human fungal pathogen Cryptococcus neoformans. PLoS Pathog. 2007, 3:e22.
22. Chun C.D., Madhani H.D. Ctr2 links copper homeostasis to polysaccharide capsule formation and phagocytosis inhibition in the human fungal pathogen Cryptococcus neoformans. PLoS One 2010, 5.
23. Coenjaerts F.E., Hoepelman A.I., Scharringa J., Aarts M., Ellerbroek P.M., Bevaart L., Van Strijp J.A., Janbon G. The Skn7 response regulator of Cryptococcus neoformans is involved in oxidative stress signalling and augments intracellular survival in endothelium. FEMS Yeast Res. 2006, 6:652-661.
24. Cox G.M., Mukherjee J., Cole G.T., Casadevall A., Perfect J.R. Urease as a virulence factor in experimental cryptococcosis. Infect. Immun. 2000, 68:443-448.
25. Cox G.M., McDade H.C., Chen S.C., Tucker S.C., Gottfredsson M., Wright L.C., Sorrell T.C., Leidich S.D., Casadevall A., Ghannoum M.A., Perfect J.R. Extracellular phospholipase activity is a virulence factor for Cryptococcus neoformans. Mol. Microbiol. 2001, 39:166-175.
26. Cox G.M., Harrison T.S., McDade H.C., Taborda C.P., Heinrich G., Casadevall A., Perfect J.R. Superoxide dismutase influences the virulence of Cryptococcus neoformans by affecting growth within macrophages. Infect. Immun. 2003, 71:173-180.
27. D'Souza C.A., Alspaugh J.A., Yue C., Harashima T., Cox G.M., Perfect J.R., Heitman J. Cyclic AMP-dependent protein kinase controls virulence of the fungal pathogen Cryptococcus neoformans. Mol. Cell. Biol. 2001, 21:3179-3191.
28. Djordjevic J.T. Role of phospholipases in fungal fitness, pathogenicity, and drug development - lessons from Cryptococcus neoformans. Front. Microbiol. 2010, 1:125.
29. Dromer F., Mathoulin-Pelissier S., Launay O., Lortholary O. Determinants of disease presentation and outcome during cryptococcosis: the CryptoA/D study. PLoS Med. 2007, 4:e21.
30. Fan W., Kraus P.R., Boily M.J., Heitman J. Cryptococcus neoformans gene expression during murine macrophage infection. Eukaryot. Cell 2005, 4:1420-1433.
31. Feldmesser M., Kress Y., Novikoff P., Casadevall A. Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmonary infection. Infect. Immun. 2000, 68:4225-4237.
32. Garcia-Rivera J., Chang Y.C., Kwon-Chung K.J., Casadevall A. Cryptococcus neoformans CAP59 (or Cap59p) is involved in the extracellular trafficking of capsular glucuronoxylomannan. Eukaryot. Cell 2004, 3:385-392.
33. Geunes-Boyer S., Oliver T.N., Janbon G., Lodge J.K., Heitman J., Perfect J.R., Wright J.R. Surfactant protein D increases phagocytosis of hypocapsular Cryptococcus neoformans by murine macrophages and enhances fungal survival. Infect. Immun. 2009, 77:2783-2794.
34. Giles S.S., Batinic-Haberle I., Perfect J.R., Cox G.M. Cryptococcus neoformans mitochondrial superoxide dismutase: an essential link between antioxidant function and high-temperature growth. Eukaryot. Cell 2005, 4:46-54.
35. Giles S.S., Zaas A.K., Reidy M.F., Perfect J.R., Wright J.R. Cryptococcus neoformans is resistant to surfactant protein A mediated host defense mechanisms. PLoS One 2007, 2:e1370.
36. Heitman J., Kozel T.R., Kwon-Chung K.J., Perfect J.R., Casadevall A. From Human Pathogen to Model Yeast 2011, ASM Press, Washington, D.C.
37. Hu G., Cheng P.Y., Sham A., Perfect J.R., Kronstad J.W. Metabolic adaptation in Cryptococcus neoformans during early murine pulmonary infection. Mol. Microbiol. 2008, 69:1456-1475.
38. Hu G., Hacham M., Waterman S.R., Panepinto J., Shin S., Liu X., Gibbons J., Valyi-Nagy T., Obara K., Jaffe H.A., Ohsumi Y., Williamson P.R. PI3K signaling of autophagy is required for starvation tolerance and virulence of Cryptococcus neoformans. J. Clin. Invest. 2008, 118:1186-1197.
39. Idnurm A., Walton F.J., Floyd A., Reedy J.L., Heitman J. Identification of ENA1 as a virulence gene of the human pathogenic fungus Cryptococcus neoformans through signature-tagged insertional mutagenesis. Eukaryot. Cell 2009, 8:315-326.
40. Jiang N., Sun N., Xiao D., Pan J., Wang Y., Zhu X. A copper-responsive factor gene CUF1 is required for copper induction of laccase in Cryptococcus neoformans. FEMS Microbiol. Lett. 2009, 296:84-90.
41. Jong A., Wu C.H., Chen H.M., Luo F., Kwon-Chung K.J., Chang Y.C., Lamunyon C.W., Plaas A., Huang S.H. Identification and characterization of CPS1 as a hyaluronic acid synthase contributing to the pathogenesis of Cryptococcus neoformans infection. Eukaryot. Cell 2007, 6:1486-1496.
42. Jong A., Wu C.H., Shackleford G.M., Kwon-Chung K.J., Chang Y.C., Chen H.M., Ouyang Y., Huang S.H. Involvement of human CD44 during Cryptococcus neoformans infection of brain microvascular endothelial cells. Cell Microbiol. 2008, 10:1313-1326.
43. Jong A.Y., Stins M.F., Huang S.H., Chen S.H., Kim K.S. Traversal of Candida albicans across human blood-brain barrier in vitro. Infect. Immun. 2001, 69:4536-4544.
44. Jung W.H., Sham A., Lian T., Singh A., Kosman D.J., Kronstad J.W. Iron source preference and regulation of iron uptake in Cryptococcus neoformans. PLoS Pathog. 2008, 4:e45.
45. Kechichian T.B., Shea J., Del Poeta M. Depletion of alveolar macrophages decreases the dissemination of a glucosylceramide-deficient mutant of Cryptococcus neoformans in immunodeficient mice. Infect. Immun. 2007, 75:4792-4798.
46. Kim K.S. E. coli invasion of brain microvascular endothelial cells as a pathogenetic basis of meningitis. Subcell. Biochem. 2000, 33:47-59.
47. Kim K.S. Mechanisms of microbial traversal of the blood-brain barrier. Nat. Rev. Microbiol. 2008, 6:625-634.
48. Klutts J.S., Doering T.L. Cryptococcal xylosyltransferase 1 (Cxt1p) from Cryptococcus neoformans plays a direct role in the synthesis of capsule polysaccharides. J. Biol. Chem. 2008, 283:14327-14334.
49. Kronstad J., Saikia S., Nielson E.D., Kretschmer M., Jung W., Hu G., Geddes J.M., Griffiths E.J., Choi J., Cadieux B., Caza M., Attarian R. Adaptation of Cryptococcus neoformans to mammalian hosts: integrated regulation of metabolism and virulence. Eukaryot. Cell 2012, 11:109-118.
50. Kronstad J.W., Attarian R., Cadieux B., Choi J., D'Souza C.A., Griffiths E.J., Geddes J.M., Hu G., Jung W.H., Kretschmer M., Saikia S., Wang J. Expanding fungal pathogenesis: Cryptococcus breaks out of the opportunistic box. Nat. Rev. Microbiol. 2011, 9:193-203.
51. Lee A., Toffaletti D.L., Tenor J., Soderblom E.J., Thompson J.W., Moseley M.A., Price M., Perfect J.R. Survival defects of Cryptococcus neoformans mutants exposed to human cerebrospinal fluid result in attenuated virulence in an experimental model of meningitis. Infect. Immun. 2010, 78:4213-4225.
52. Liu G.Y., Nizet V. Color me bad: microbial pigments as virulence factors. Trends Microbiol. 2009, 17:406-413.
53. Liu O.W., Chun C.D., Chow E.D., Chen C., Madhani H.D., Noble S.M. Systematic genetic analysis of virulence in the human fungal pathogen Cryptococcus neoformans. Cell 2008, 135:174-188.
54. Lortholary O., Improvisi L., Nicolas M., Provost F., Dupont B., Dromer F. Fungemia during murine cryptococcosis sheds some light on pathophysiology. Med. Mycol. 1999, 37:169-174.
55. Luberto C., Martinez-Mariño B., Taraskiewicz D., Bolaños B., Chitano P., Toffaletti D.L., Cox G.M., Perfect J.R., Hannun Y.A., Balish E., Del Poeta M. Identification of App1 as a regulator of phagocytosis and virulence of Cryptococcus neoformans. J. Clin. Invest. 2003, 112:1080-1094.
56. Luberto C., Toffaletti D.L., Wills E.A., Tucker S.C., Casadevall A., Perfect J.R., Hannun Y.A., Del Poeta M. Roles for inositol-phosphoryl ceramide synthase 1 (IPC1) in pathogenesis of C. neoformans. Genes Dev. 2001, 15:201-212.
57. Ma H., Croudace J.E., Lammas D.A., May R.C. Expulsion of live pathogenic yeast by macrophages. Curr. Biol. 2006, 16:2156-2160.
58. Ma H., Croudace J.E., Lammas D.A., May R.C. Direct cell-to-cell spread of a pathogenic yeast. BMC Immunol. 2007, 8:15.
59. Merkel G.J., Scofield B.A. The in vitro interaction of Cryptococcus neoformans with human lung epithelial cells. FEMS Immunol. Med. Microbiol. 1997, 19:203-213.
60. Moyrand F., Klaproth B., Himmelreich U., Dromer F., Janbon G. Isolation and characterization of capsule structure mutant strains of Cryptococcus neoformans. Mol. Microbiol. 2002, 45:837-849.
61. Moyrand F., Chang Y.C., Himmelreich U., Kwon-Chung K.J., Janbon G. Cas3p belongs to a seven-member family of capsule structure designer proteins. Eukaryot. Cell 2004, 3:1513-1524.
62. Moyrand F., Fontaine T., Janbon G. Systematic capsule gene disruption reveals the central role of galactose metabolism on Cryptococcus neoformans virulence. Mol. Microbiol. 2007, 64:771-781.
63. Moyrand F., Lafontaine I., Fontaine T., Janbon G. UGE1 and UGE2 regulate the UDP-glucose/UDP-galactose equilibrium in Cryptococcus neoformans. Eukaryot. Cell 2008, 7:2069-2077.
64. Mylonakis E., Idnurm A., Moreno R., El Khoury J., Rottman J.B., Ausubel F.M., Heitman J., Calderwood S.B. Cryptococcus neoformans Kin1 protein kinase homologue, identified through a Caenorhabditis elegans screen, promotes virulence in mammals. Mol. Microbiol. 2004, 54:407-419.
65. Narasipura S.D., Chaturvedi V., Chaturvedi S. Characterization of Cryptococcus neoformans variety gattii SOD2 reveals distinct roles of the two superoxide dismutases in fungal biology and virulence. Mol. Microbiol. 2005, 55:1782-1800.
66. Ngamskulrungroj P., Himmelreich U., Breger J.A., Wilson C., Chayakulkeeree M., Krockenberger M.B., Malik R., Daniel H.M., Toffaletti D., Djordjevic J.T., Mylonakis E., Meyer W., Perfect J.R. The trehalose synthesis pathway is an integral part of the virulence composite for Cryptococcus gattii. Infect. Immun. 2009, 77:4584-4596.
67. Nizet V., Kim K.S., Stins M., Jonas M., Chi E.Y., Nguyen D., Rubens C.E. Invasion of brain microvascular endothelial cells by group B streptococci. Infect. Immun. 1997, 65:5074-5081.
68. Noverr M.C., Cox G.M., Perfect J.R., Huffnagle G.B. Role of PLB1 in pulmonary inflammation and cryptococcal eicosanoid production. Infect. Immun. 2003, 71:1538-1547.
69. Noverr M.C., Williamson P.R., Fajardo R.S., Huffnagle G.B. CNLAC1 is required for extrapulmonary dissemination of Cryptococcus neoformans but not pulmonary persistence. Infect. Immun. 2004, 72:1693-1699.
70. Novick P., Field C., Schekman R. Identification of 23 complementation groups required for post-translational events in the yeast secretory pathway. Cell 1980, 21:205-215.
71. Okagaki L.H., Strain A.K., Nielsen J.N., Charlier C., Baltes N.J., Chretien F., Heitman J., Dromer F., Nielsen K. Cryptococcal cell morphology affects host cell interactions and pathogenicity. PLoS Pathog. 2010, 6:e1000953.
72. Olszewski M.A., Noverr M.C., Chen G.H., Toews G.B., Cox G.M., Perfect J.R., Huffnagle G.B. Urease expression by Cryptococcus neoformans promotes microvascular sequestration, thereby enhancing central nervous system invasion. Am. J. Pathol. 2004, 164:1761-1771.
73. Panepinto J., Komperda K., Frases S., Park Y.D., Djordjevic J.T., Casadevall A., Williamson P.R. Sec6-dependent sorting of fungal extracellular exosomes and laccase of Cryptococcus neoformans. Mol. Microbiol. 2009, 71:1165-1176.
74. Panepinto J.C., Williamson P.R. Intersection of fungal fitness and virulence in Cryptococcus neoformans. FEMS Yeast Res. 2006, 6:489-498.
75. Park B.J., Wannemuehler K.A., Marston B.J., Govender N., Pappas P.G., Chiller T.M. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 2009, 23:525-530.
76. Perfect J.R., Lang S.D., Durack D.T. Chronic cryptococcal meningitis: a new experimental model in rabbits. Am. J. Pathol. 1980, 101:177-194.
77. Petzold E.W., Himmelreich U., Mylonakis E., Rude T., Toffaletti D., Cox G.M., Miller J.L., Perfect J.R. Characterization and regulation of the trehalose synthesis pathway and its importance in the pathogenicity of Cryptococcus neoformans. Infect. Immun. 2006, 74:5877-5887.
78. Price M.S., Betancourt-Quiroz M., Price J.L., Toffaletti D.L., Vora H., Hu G., Kronstad J.W., Perfect J.R. Cryptococcus neoformans requires a functional glycolytic pathway for disease but not persistence in the host. MBio 2011, 2:e00103-e00111.
79. Price M.S., Nichols C.B., Alspaugh J.A. The Cryptococcus neoformans Rho-GDP dissociation inhibitor mediates intracellular survival and virulence. Infect. Immun. 2008, 76:5729-5737.
80. Rittershaus P.C., Kechichian T.B., Allegood J.C., Merrill A.H., Hennig M., Luberto C., Del Poeta M. Glucosylceramide synthase is an essential regulator of pathogenicity of Cryptococcus neoformans. J. Clin. Invest. 2006, 116:1651-1659.
81. Rodrigues M.L., Travassos L.R., Miranda K.R., Franzen A.J., Rozental S., de Souza W., Alviano C.S., Barreto-Bergter E. Human antibodies against a purified glucosylceramide from Cryptococcus neoformans inhibit cell budding and fungal growth. Infect. Immun. 2000, 68:7049-7060.
82. Sahn S. The value of pleural fluid analysis. Am. J. Med. Sci. 2007, 335:7-15.
83. Salas S.D., Bennett J.E., Kwon-Chung K.J., Perfect J.R., Williamson P.R. Effect of the laccase gene CNLAC1, on virulence of Cryptococcus neoformans. J. Exp. Med. 1996, 184:377-386.
84. Santangelo R., Zoellner H., Sorrell T., Wilson C., Donald C., Djordjevic J., Shounan Y., Wright L. Role of extracellular phospholipases and mononuclear phagocytes in dissemination of cryptococcosis in a murine model. Infect. Immun. 2004, 72:2229-2239.
85. Schaible B., Schaffer K., Taylor C.T. Hypoxia, innate immunity and infection in the lung. Respir. Physiol. Neurobiol. 2010, 174:235-243.
86. Shea J.M., Del Poeta M. Lipid signaling in pathogenic fungi. Curr. Opin. Microbiol. 2006, 9:352-358.
87. Shea J.M., Kechichian T.B., Luberto C., Del Poeta M. The cryptococcal enzyme inositol phosphosphingolipid-phospholipase C confers resistance to the antifungal effects of macrophages and promotes fungal dissemination to the central nervous system. Infect. Immun. 2006, 74:5977-5988.
88. Shen G., Wang Y.L., Whittington A., Li L., Wang P. The RGS protein Crg2 regulates pheromone and cyclic AMP signaling in Cryptococcus neoformans. Eukaryot. Cell 2008, 7:1540-1548.
89. Shen G., Whittington A., Song K., Wang P. Pleiotropic function of intersectin homologue Cin1 in Cryptococcus neoformans. Mol. Microbiol. 2010, 76:662-676.
90. Shen G., Whittington A., Wang P. Wsp1, a GBD/CRIB domain-containing WASP homolog, is required for growth, morphogenesis, and virulence of Cryptococcus neoformans. Eukaryot. Cell 2011, 10:521-529.
91. Shi M., Li S.S., Zheng C., Jones G.J., Kim K.S., Zhou H., Kubes P., Mody C.H. Real-time imaging of trapping and urease-dependent transmigration of Cryptococcus neoformans in mouse brain. J. Clin. Invest. 2010, 120:1683-1693.
92. Stie J., Bruni G., Fox D. Surface-associated plasminogen binding of Cryptococcus neoformans promotes extracellular matrix invasion. PLoS One 2009, 4:e5780.
93. Stie J.T., Fox D.S. Bloodebrain barrier invasion by Cryptococcus neoformans is enhanced by functional interactions with plasmin. Microbiol 2012, 158:240-258.
94. Thompson E.J., Keir G. Laboratory investigation of cerebrospinal fluid protein. Ann. Clin. Biochem. 1990, 27:425-435.
95. Vu K., Weksler B., Romero I., Couraud P.O., Gelli A. Immortalized human brain endothelial cell line HCMEC/D3 as a model of the blood-brain barrier facilitates in vitro studies of central nervous system infection by Cryptococcus neoformans. Eukaryot. Cell 2009, 8:1803-1807.
96. Waterman S.R., Hacham M., Hu G., Zhu X., Park Y.D., Shin S., Panepinto J., Valyi-Nagy T., Beam C., Husain S., Singh N., Williamson P.R. Role of a CUF1/CTR4 copper regulatory axis in the virulence of Cryptococcus neoformans. J. Clin. Invest. 2007, 117:794-802.
97. Waterman S.R., Hacham M., Panepinto J., Hu G., Shin S., Williamson P.R. Cell wall targeting of laccase of Cryptococcus neoformans during infection of mice. Infect. Immun. 2007, 75:714-722.
98. Waugh M.S., Nichols C.B., DeCesare C.M., Cox G.M., Heitman J., Alspaugh J.A. Ras1 and Ras2 contribute shared and unique roles in physiology and virulence of Cryptococcus neoformans. Microbiology 2002, 148:191-201.
99. Waugh A., Allison G. Anatomy and Physiology in Health and Illness 2007, Churchill Livingstone Elsevier.
100. Whittington A., Wang P. The RGS protein Crg2 is required for establishment and progression of murine pulmonary cryptococcosis. Med. Mycol. 2011, 49:263-275.
101. Wilder J.A., Olson G.K., Chang Y.C., Kwon-Chung K.J., Lipscomb M.F. Complementation of a capsule deficient Cryptococcus neoformans with CAP64 restores virulence in a murine lung infection. Am. J. Respir. Cell. Mol. Biol. 2002, 26:306-314.
102. Wormley F.L., Heinrich G., Miller J.L., Perfect J.R., Cox G.M. Identification and characterization of an SKN7 homologue in Cryptococcus neoformans. Infect. Immun. 2005, 73:5022-5030.
103. Xue C., Hsueh Y.P., Chen L., Heitman J. The RGS protein Crg2 regulates both pheromone and cAMP signalling in Cryptococcus neoformans. Mol. Microbiol. 2008, 70:379-395.
104. Yang J., Li D., Liu X., Pan J., Yan B., Zhu X. Regulation of virulence factors, carbon utilization and virulence by SNF1 in Cryptococcus neoformans JEC21 and divergent actions of SNF1 between cryptococcal strains. Fungal Genet. Biol. 2010, 47:994-1000.
105. Zaragoza O., Rodrigues M.L., De Jesus M., Frases S., Dadachova E., Casadevall A. The capsule of the fungal pathogen Cryptococcus neoformans. Adv. Appl. Microbiol. 2009, 68:133-216.
106. Zaragoza O., Garcia-Rodas R., Nosanchuk J.D., Cuenca-Estrella M., Rodriguez-Tudela J.L., Casadevall A. Fungal cell gigantism during mammalian infection. PLoS Pathog. 2010, 6:e1000945.
107. Zhu X., Williamson P.R. Role of laccase in the biology and virulence of Cryptococcus neoformans. FEMS Yeast Res. 2004, 5:1-10.
108. Zink S., Nass T., Rosen P., Ernst J.F. Migration of the fungal pathogen Candida albicans across endothelial monolayers. Infect. Immun. 1996, 64:5085-5091.